Centinel Spine Expands MIDLINE II-Ti in U.S. and Australia
By Julie A. Vetalice
Centinel Spine expanded its MIDLINE II-Ti product family in the U.S. and Australia.MIDLINE II-Ti is the company's most recent device for anterior lumbar interbody fusion, representing the sixth generation of its STALIF® technology. MIDLINE II-Ti blends the STALIF Integrated Interbody device with Ti-ACTIVE, a texturized, microporous titanium plasma coating, to approach ALIF procedures with 8°, 12°, 16° and 20° of lordosis, radiographic visualization and three cancellous screws for stability.
The device received FDA 510(k) clearance in late 2Q15. According to the company, there have been over 4,500 Ti-ACTIVE devices and ~1,000 MIDLINE II devices implanted to date.The complete STALIF product family includes STALIF C® and STALIF C-TiTM for anterior cervical discectomy fusion and STALIF LTM for lateral lumbar interbody fusion.
Source: Centinel Spine, Inc.; ORTHOWORLD, Inc.
In 1Q16, Centinel Spine received FDA clearance for ALTOS™ PCT, a posterior cervical stabilization system designed for use in the cervical lateral masses or cervical-thoracic pedicles.